What is LOPJLB’s current signal on CNTB?

LOPJLB’s latest quantitative signal on Connect Biopharma Holdings Limited (CNTB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CNTB in?

Connect Biopharma Holdings Limited (CNTB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Connect Biopharma Holdings Limited (CNTB) do?

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb…

Where is Connect Biopharma Holdings Limited based / listed?

Connect Biopharma Holdings Limited is based in US, listed on NASDAQ.

Connect Biopharma Holdings Limited (CNTB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.87-1.14%Close

SELLCRISIS · day 26

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $55M
Beta: -0.22
P/E (TTM): -1.03

Short % float: 22.67%
Days to cover: 1.0
SI change: +26.2%

1W: -6.45%
1M: -57.77%

vs SPY 1W: -7.61%
vs SPY 1M: -60.76%

Industry peers

FMP comparable companies · ranked by market cap

STTKSELLShattuck Labs, Inc.$608MCRISISQ 5$6.73+5.48%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news